Impact Stories | Page 2

The multi-disciplinary team has a technical proof-of-concept. Now they need to do a clinical experiment and fine-tune the technology....

An interdisciplinary team of researchers from McMaster and SickKids are developing a cutting-edge lung model that can better respond to viruses and drug treatments, giving scientists a tool to advance research in lung conditions like COVID-19, cystic fibrosis and allergens for asthma and air pollution....

Western's ImPaKT facility site of new international research investigating new way of detecting COVID-19, variants of concern....

USask's VIDO emerges as Canada's leader in vaccine development....

One of the newest scientists at the University of Saskatchewan’s (USask) Vaccine and Infectious Disease Organization (VIDO) has published new research on potential lasting effects of COVID-19....

Meet the UBC researchers investigating the long-term impacts of the disease...

The new models open the possibility of pre-assessment for drug and vaccine efficacy against the COVID-19 virus....

British Columbia is in the midst of two public health emergencies. While the COVID-19 vaccine rollout continues across the province and country, fatal drug poisonings have been on the rise....

Unlike other population-level stressful events such as natural disasters, COVID-19 has not resulted in a net increase in smoking, according to a new study from the International Tobacco Control (ITC) Project, at the University of Waterloo....

Wastewater testing can accurately and rapidly identify levels of COVID-19 infections in the community, including the rise of variants of concern, suggests new research led by UBC professor Dr. Ryan Ziels....